Curanex Pharmaceuticals, Inc. (CURX)
4.77
-0.22
(-4.41%)
USD |
NASDAQ |
Oct 07, 16:00
4.76
-0.01
(-0.21%)
Pre-Market: 20:00
Curanex Pharmaceuticals Shareholders Equity (Quarterly) : 4.788M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.788M |
| March 31, 2026 | 8.079M |
| December 31, 2025 | 11.22M |
| September 30, 2025 | 14.29M |
| June 30, 2025 | 0.3054M |
| March 31, 2025 | 0.3658M |
| Date | Value |
|---|---|
| December 31, 2024 | 0.5034M |
| September 30, 2024 | 0.6405M |
| June 30, 2024 | 0.7152M |
| March 31, 2024 | |
| December 31, 2023 | 0.0601M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Resonate Blends, Inc. | -5.364M |
| Kaya Holdings, Inc. | -0.5474M |
| Endexx Corp. | -31.85M |
| Earth Science Tech, Inc. | 7.342M |
| Eco-Growth Strategies, Inc. | -8.953M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.074M |
| Total Liabilities (Quarterly) | 0.2863M |
| Debt to Equity Ratio | 0.0577 |
| Current Ratio | 45.95 |
| Net Debt Paydown Yield | 0.04% |